Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert

Seeking Alpha

BioBlogger » Articles |

BioBlogger

Sort by:

Latest | Editors' Picks | Most Commented | Most Popular

Encysive Pharmaceuticals Blind-Sided: Thelin Receives Approvable Letter from FDA
on Mar 28, 2006 • ENCY
FDA Delay of Tysabri Verdict Not a Surprise (BIIB, ELN)
on Mar 24, 2006 • BIIB, ELN
Nabi Biopharmaceuticals Continues Clinical Development of StaphVax (NABI)
on Mar 24, 2006 • NABI
Tysabri Comes Out On Top At FDA Panel Meeting (BIIB, ELN)
on Mar 10, 2006 • BIIB, ELN
Tysabri To Be Discussed At FDA Advisory Committee Meeting: Findings From The Briefing Documents (BIIB, ELN)
on Mar 07, 2006 • BIIB, ELN
Research Report Highlights Reality of Tysabri’s Prospects (ELN, BIIB)
on Mar 01, 2006 • BIIB, ELN
FDA Has Egg On Its Face…Again (NFLD)
on Feb 23, 2006 • NFLD
Does Adolor’s Announcement of Positive Entereg Data Assure FDA Approval? (ADLR)
on Feb 08, 2006 • ADLR
Barron’s Tepid Review of Amylin Pharmaceuticals (AMLN, PFE, NKTR, SNY, NVO)
on Feb 01, 2006 • AMLN, NKTR, NVO
Gilead Reports Another Solid Quarter (GILD, BMY)
on Jan 31, 2006 • BMY, GILD
Upheaval at Imclone (IMCL, BMY, AMGN, ABGX)
on Jan 26, 2006 • ABGX, AMGN, BMY
Fate of Serono: J&J Hires Citigroup to Examine a Formal Bid (SRA, JNJ, GDT, STJ, ELN, BIIB)
on Jan 25, 2006 • BIIB, ELN, GDT
Biotech Stocks Q4 2005 Earnings Scorecard
on Jan 24, 2006 • AFFX, ALXN, AMGN
It’s Official: FDA Panel Will Review Tysabri On March 7th (ELN, BIIB)
on Jan 23, 2006 • BIIB, ELN
BioCryst Receives Fast-Track Status for Peramivir, But Does It Justify The Stock's Appreciation? (BCRX)
on Jan 18, 2006 • BCRX
Should Pfizer Acquire Kos Pharmaceuticals? (PFE, KOSP, MRK)
on Jan 05, 2006 • KOSP, MRK, PFE
Nitromed Update: Cramer Re-Visited (NTMD)
on Jan 05, 2006 • NTMD
Amgen Makes Bid To Acquire Abgenix For $2.2 billion (AMGN, ABGX)
on Dec 15, 2005 • ABGX, AMGN, AMLN
PAH Market Heats Up: Myogen Reports Positive Data of Ambrisentan (MYOG)
on Dec 12, 2005 • ENCY, MYOG, PFE
Tysabri Panel Meeting in March? (BIIB, ELN)
on Dec 08, 2005 • BIIB, ELN
Bait And Switch: American Pharmaceutical Partners’ Proposed Acquisition of American BioScience (APPX)
on Nov 30, 2005 • APPX
Diabetes Market Heating Up: Novo Nordisk Releases Positive Liraglutide Data (AMLN, NVO)
on Nov 28, 2005 • AMLN, NVO
Report of Pediatric Deaths In Japan Linked To Tamiflu Are Overblown (RHHBY, GILD)
on Nov 17, 2005 • GILD, RHHBY.PK
Celgene Goes 0-for-4 With Thalomid (CELG)
on Nov 16, 2005 • CELG
Rumor Du Jour: Wyeth Looking at Acquiring Elan (WYE, ELN)
on Nov 16, 2005 • ELN, WYE
MGI Pharma and Supergen Respond to FDA Approvable Letter and Pull MAA in Europe (MOGN, SUPG, PHRM)
on Nov 16, 2005 • MOGN, PHRM, SUPG
The Hidden M.O. Behind Jim Cramer's "Bullish" Call on Nitromed (NTMD)
on Nov 09, 2005 • NTMD
Nexavar (aka, Sorafenib) Phase 3 Data Released at ECCO (ONXX, BAY, PFE)
on Nov 08, 2005 • BAYRY.PK, ONXX, PFE
Panitumumab Data and the Implications for Erbitux (ABGX, AMGN, IMCL)
on Nov 08, 2005 • ABGX, AMGN, IMCL
The President's Avian Flu Plan: Boon or Bust for the Speculators? (BCRX, GILD, QDEL, RHHBY)
on Nov 03, 2005 • BCRX, GILD, QDEL
Medimmune Q3 Earnings Overview (MEDI)
on Nov 02, 2005 • ABT, AZN
Imclone Q3 Earnings Overview (IMCL)
on Nov 02, 2005 • BMY, IMCL

Articles by Ticker

Latest Comments on BioBlogger's Articles

UserThunderBolt on Research Report Highlights Reality of Tysabri’s Prospects (ELN, BIIB): I love these obscure pieces. more »
avian on BioCryst and Avian Flu: Underappreciated Call Option or Just Overhyped? (BCRX): Avian flu or bird flu is a contagious disease of birds caused by... more »
BioBlogger_ on Tysabri Comes Out On Top At FDA Panel Meeting (BIIB, ELN): I agree completely. With BIIB you have the diversified business... more »
BioBlogger_ on FDA Has Egg On Its Face…Again (NFLD): I agree with many of the comments to my post. There are certainly... more »
User 1 on Research Report Highlights Reality of Tysabri’s Prospects (ELN, BIIB): Richard, This is David Jackson, Seeking Alpha founder. My goal... more »
BioBlogger_ on Research Report Highlights Reality of Tysabri’s Prospects (ELN, BIIB): If your going to criticize my analysis, then support your... more »
BioBlogger_ on BioCryst Receives Fast-Track Status for Peramivir, But Does It Justify The Stock's Appreciation? (BCRX): The market does have the potential to be significant; however, I... more »
onewaystox on BioCryst Receives Fast-Track Status for Peramivir, But Does It Justify The Stock's Appreciation? (BCRX): this is (potentially) a pretty big mkt for BCRX to get into. And... more »
skepticjr on The Hidden M.O. Behind Jim Cramer's "Bullish" Call on Nitromed (NTMD): Bravo. more »
BioBlogger_ on The Future of Tysabri: A Reader’s Perspective (ELN, BIIB, SRA): Boswells, One more thing. Thank you very much for your comment. more »
BioBlogger_ on The Future of Tysabri: A Reader’s Perspective (ELN, BIIB, SRA): Your point is well taken. I would not be surprised if Tysabri... more »
boswells on The Future of Tysabri: A Reader’s Perspective (ELN, BIIB, SRA): This is all well an fine that you can quote rates, market share... more »
BioBlogger_ on BioCryst and Avian Flu: Underappreciated Call Option or Just Overhyped? (BCRX): Hey, skepticjr, thanks for the post. No Stuart MacKenzie quotes? ... more »
skepticjr on BioCryst and Avian Flu: Underappreciated Call Option or Just Overhyped? (BCRX): How about a discussion of stocks who may still have some flu... more »
skepticjr on Some Facts About Avian Flu (GILD, GLX): Love how the media frenzy covering avian flu fails to address need... more »

Latest Comments on BioBlogger's Articles